(Q43490218)

English

Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality

scientific article published on 17 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

decompensated cirrhosis

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

H W Zimmermann

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

P A Reuken

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A Koch

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

M Bartneck

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

C Trautwein

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A Stallmach

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

F Tacke

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

T Bruns

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

17 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

274

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

86-100

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Mortality after urinary tract infections in patients with advanced cirrhosis - Relevance of acute kidney injury and comorbidities

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Regulation of cell signalling by uPAR.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Identification of bacterial DNA in neutrocytic and non-neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87).

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Enhanced monocyte activation and hepatotoxicity in response to endotoxin in portal hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12054

21 January 2018

Identifiers

10.1111/JOIM.12054

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43490218&oldid=1989817481"